Advertisement

Reactions Weekly

, Volume 1658, Issue 1, pp 355–355 | Cite as

Nivolumab

Various toxicities: 3 case reports
Case report
  • 23 Downloads

Reference

  1. Brito-Dellan N. Toxicities of the anti-PD-1 immune checkpoint antibody Nivolumab in the acute inpatient setting. Supportive Care in Cancer 24 (Suppl. 1): s189 abstr. eP313, Jun 2016. Available from: URL: http://doi.org/10.1007/s00520-016-3209-z [abstract] - USA

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations